• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水性药物自递药系统作为一种多功能纳米平台用于癌症治疗:综述。

Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review.

机构信息

Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China; State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai 264003, PR China.

Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Department of Chemical Engineering and Material Science, Wayne State University, Detroit, MI 48202, USA.

出版信息

Colloids Surf B Biointerfaces. 2019 Aug 1;180:202-211. doi: 10.1016/j.colsurfb.2019.04.050. Epub 2019 Apr 25.

DOI:10.1016/j.colsurfb.2019.04.050
PMID:31054460
Abstract

Drug self-delivery systems exactly present nanoscale characteristics without the support of any external carrier materials, have been rapidly developed because of low-cost preparation, excellent and fixed drug loading capacity, no need for carrier synthesis and no carrier-induced toxicity and immunogenicity. In general, amphipathy is indispensable for such design, for the amphiphilic drug conjugates could spontaneously self-assemble into nano-sized architectures above a critical concentration. Nevertheless, some elaborate designs on bonds and specified conjugates with no amphipathy anymore appeared in recent years, which create a novel and broad platform for the fabrication of hydrophobic drug self-delivery systems (HDSDSs), involving lipid-drug conjugates, drug-drug conjugates, and fluorescent dye -drug conjugates. In this review, we present the major types of HDSDSs and expound their self-assembly mechanism and fabrication strategies. And we emphatically discuss some representative achievements of these different types of HDSDSs for monotherapy, combinational therapy and theranostics in the aspect of cancer therapy. In addition, we discuss the future prospects of such kind of nanomedicine, which hold a span-new direction for cancer therapy on account of the excellent drug behavior in vitro and in vivo and the great potential to standardize the commercial production.

摘要

药物自传递系统无需任何外部载体材料的支持即可呈现出纳米级特征,由于其低成本的制备、出色且固定的载药量、无需载体合成以及载体引起的毒性和免疫原性等优点,因此得到了快速发展。一般来说,这种设计离不开两亲性,因为两亲性药物缀合物在临界浓度以上会自发自组装成纳米尺寸的结构。然而,近年来出现了一些在键和特定缀合物上的精心设计,这些设计不再需要两亲性,为疏水性药物自传递系统(HDSDS)的制备创造了一个新颖而广阔的平台,涉及脂质-药物缀合物、药物-药物缀合物和荧光染料-药物缀合物。在这篇综述中,我们介绍了 HDSDS 的主要类型,并阐述了它们的自组装机制和制备策略。我们还着重讨论了这些不同类型的 HDSDS 在癌症治疗方面的单药治疗、联合治疗和治疗学方面的一些代表性成就。此外,我们还讨论了这种纳米医学的未来前景,由于其在体外和体内具有优异的药物行为以及使商业化生产标准化的巨大潜力,为癌症治疗开辟了全新的方向。

相似文献

1
Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review.疏水性药物自递药系统作为一种多功能纳米平台用于癌症治疗:综述。
Colloids Surf B Biointerfaces. 2019 Aug 1;180:202-211. doi: 10.1016/j.colsurfb.2019.04.050. Epub 2019 Apr 25.
2
Drug self-delivery systems for cancer therapy.癌症治疗的药物自传递系统。
Biomaterials. 2017 Jan;112:234-247. doi: 10.1016/j.biomaterials.2016.10.016. Epub 2016 Oct 13.
3
Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.化疗药物-光热剂共自组装纳米粒子用于近红外荧光和光声双模成像引导的化疗-光热协同治疗。
J Control Release. 2017 Jul 28;258:95-107. doi: 10.1016/j.jconrel.2017.05.011. Epub 2017 May 10.
4
Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.基于纤维素的纳米药物传递系统的最新进展:前药和纳米粒子的设计。
Curr Med Chem. 2019;26(14):2410-2429. doi: 10.2174/0929867324666170711131353.
5
Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.基于甲氨蝶呤的两亲性前药纳米聚集体用于联合多种治疗药物和协同癌症治疗。
Acta Biomater. 2018 Sep 1;77:228-239. doi: 10.1016/j.actbio.2018.07.014. Epub 2018 Jul 10.
6
Self-Assembled Oxaliplatin(IV) Prodrug-Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy.自组装奥沙利铂(IV)前药-卟啉缀合物用于联合光动力疗法和化学疗法。
ACS Appl Mater Interfaces. 2019 May 8;11(18):16391-16401. doi: 10.1021/acsami.9b04557. Epub 2019 Apr 26.
7
Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy.自组装的双重疏水性前药纳米粒子,由喜树碱类似物构建,用于癌症治疗。
Eur J Med Chem. 2020 Aug 15;200:112365. doi: 10.1016/j.ejmech.2020.112365. Epub 2020 Apr 30.
8
Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.甲氨蝶呤-喜树碱前药纳米组装体作为一种多功能的纳米平台,用于双模态成像引导的自激活靶向和协同化疗。
ACS Appl Mater Interfaces. 2017 Oct 11;9(40):34650-34665. doi: 10.1021/acsami.7b10027. Epub 2017 Sep 25.
9
A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.一种由两亲性靶向配体-化疗药物偶联物组成的小分子纳米药物,用于靶向癌症治疗。
J Control Release. 2016 May 28;230:34-44. doi: 10.1016/j.jconrel.2016.03.037. Epub 2016 Mar 31.
10
Self-Assembled Nanoparticles of Amphiphilic Twin Drug from Floxuridine and Bendamustine for Cancer Therapy.由氟尿苷和苯达莫司汀组成的两亲性双药自组装纳米颗粒用于癌症治疗
Mol Pharm. 2015 Jul 6;12(7):2328-36. doi: 10.1021/acs.molpharmaceut.5b00005. Epub 2015 Jun 3.

引用本文的文献

1
Drug self-delivery systems: A comprehensive review on small molecule nanodrugs.药物自递送系统:小分子纳米药物综述
Bioimpacts. 2024 Oct 27;15:30161. doi: 10.34172/bi.30161. eCollection 2025.
2
Advances in Pure Drug Self-Assembled Nanosystems: A Novel Strategy for Combined Cancer Therapy.纯药物自组装纳米系统的进展:一种联合癌症治疗的新策略。
Pharmaceutics. 2025 Jan 6;17(1):68. doi: 10.3390/pharmaceutics17010068.
3
Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment.载药型纳米药物递药系统的组装机制研究进展。
Molecules. 2023 Oct 13;28(20):7065. doi: 10.3390/molecules28207065.
4
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics.用于增强癌症诊疗的紫杉醇自组装纳米制剂。
Acta Pharm Sin B. 2023 Aug;13(8):3252-3276. doi: 10.1016/j.apsb.2023.02.021. Epub 2023 Mar 5.
5
Synthesis of Carrier-Free Paclitaxel-Curcumin Nanoparticles: The Role of Curcuminoids.无载体紫杉醇-姜黄素纳米颗粒的合成:姜黄素类化合物的作用
Bioengineering (Basel). 2022 Dec 18;9(12):815. doi: 10.3390/bioengineering9120815.
6
One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics.用于癌症治疗的两亲性阿霉素前药纳米胶束的一锅法合成及其酶响应性
RSC Adv. 2022 Sep 30;12(43):27963-27969. doi: 10.1039/d2ra04436f. eCollection 2022 Sep 28.
7
Photoresponsive prodrug-dye nanoassembly for in-situ monitorable cancer therapy.用于原位可监测癌症治疗的光响应性前药-染料纳米组装体。
Bioeng Transl Med. 2022 Mar 12;7(3):e10311. doi: 10.1002/btm2.10311. eCollection 2022 Sep.
8
Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system.使用阿霉素-阿霉素二聚体混合纳米颗粒作为pH触发型药物自递送系统来调控药物释放性能。
J Pharm Anal. 2022 Feb;12(1):122-128. doi: 10.1016/j.jpha.2021.03.001. Epub 2021 Mar 9.
9
Superior antitumor effect of self-assembly supramolecular paclitaxel nanoparticles.自组装超分子紫杉醇纳米粒具有卓越的抗肿瘤效果。
RSC Adv. 2020 Mar 31;10(22):12999-13005. doi: 10.1039/d0ra01117g. eCollection 2020 Mar 30.
10
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.氧化铁纳米颗粒靶向化学免疫疗法治疗三阴性乳腺癌
Mater Today (Kidlington). 2021 Nov;50:149-169. doi: 10.1016/j.mattod.2021.08.002. Epub 2021 Sep 7.